A lab-engineered probiotic, composed of live bacteria that colonize the gut, was able to ease signs of disease in a mouse model of multiple sclerosis (MS), according to recent research.
After discovering that a metabolite called lactate could activate immune signaling pathways that help to curb autoimmunity, scientists specifically engineered the bacteria to release it.
With further study, scientists believe that these specialized probiotics could be beneficial for patients living with many different autoimmune diseases, including MS.
